Aldeyra Allergic Conjunctivitis Drug Has Good Prospects With Phase III Results

Warming Temperatures Expand Market Potential

 
• By Alaric DeArment
Eye
ALDEYRA ANNOUNCES POSITIVE DATA IN PHASE III ALLERGIC CONJUNCTIVITIS STUDY • Source: Shutterstock

More from Clinical Trials

More from R&D